Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2001
11/21/2001CN1323307A 1H-imidazopyridine derivatives
11/21/2001CN1323298A New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists
11/21/2001CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/20/2001US6319929 Suksdorfin analogs, compositions thereof, and methods for making and using thereof
11/20/2001US6319919 Inhibiting acetyl cholinesterase activity
11/20/2001CA2176668C Heterocyclic spiro compounds, process for preparing the same and pharmaceutical compositions containing them
11/20/2001CA2024843C Synthesis of mannojirimycin derivatives
11/20/2001CA2012507C Non-migrating 1-hydrocarbyloxy hindered amine compounds as polymer stabilizers
11/15/2001WO2001085749A1 Anti-viral pyrimidine nucleoside analogues
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001WO2001057043A8 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis
11/15/2001US20010041715 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/15/2001US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001US20010041707 Selective antagonists for human alpha 1a receptors; benign prostatic hyperplasia; (+)-1-3-((4-(3,4-difluorophenyl)-2,5-dioxo-1,2,5,7-tetrahydro-4H-furo(3,4 -d)pyrimidine-3-carbonyl)amino)-propyl-4-(2-pyridyl)-piperidine
11/15/2001US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001CA2406633A1 Anti-viral pyrimidine nucleoside analogues
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP0706527B1 Substituted spiroheterocyclic 1h-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/14/2001CN1321643A Nabufulin polybasic ester derivative and its production method
11/13/2001US6316624 Process for the preparation of substituted 8-azabicyclo[3,2,1]octanes
11/13/2001US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001US6316464 P38 MAP kinase inhibitors
11/13/2001US6316439 Galanthamine derivatives as acetylcholinesterase inhibitors
11/13/2001US6316437 Spirohydantoin compounds and uses thereof
11/13/2001US6316388 Antigrowth agents for plants
11/13/2001US6316214 ETM-775 metabolite of ecteinascidin 743
11/13/2001US6315978 Bioconjugates and delivery of bioactive agents
11/08/2001WO2001083800A2 Heterologous production of polyketides
11/08/2001WO2001083501A1 Anti-viral pyrimidine nucleoside analogues
11/08/2001WO2001083487A1 Froindazole derivative
11/08/2001WO2001083484A1 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/08/2001WO2001083480A2 Dihydropyridine compounds and methods of use
11/08/2001WO2001083476A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/08/2001WO2001083456A1 Condensed heteroaryl derivatives
11/08/2001WO2001032632A3 Pharmaceutically active 4-substituted pyrimidine derivatives
11/08/2001WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001US20010039355 One pot process
11/08/2001US20010039287 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/08/2001CA2407317A1 Dihydropyridine compounds and methods of use
11/08/2001CA2405614A1 Chromenylmethyl pyrimidinediamines as antibacterial agents
11/07/2001EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001EP0835108B1 Use of lamellarin-class alkaloids in methods of treatment
11/07/2001EP0777478B1 Inhibitors of rotamase enzyme activity
11/07/2001CN1321158A Tricyclic delta 3-piperidines as pharmaceuticals
11/07/2001CN1074251C Fungicidal compositions
11/06/2001US6313138 Tyrosine kinase inhibitors
11/06/2001US6313135 Analogues of camptothecin, preparation procedures, their application as medicines and the pharmaceutical compositions comprising them
11/01/2001WO2001081350A1 Oxazolidinone derivatives with antibiotic activity
11/01/2001WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001WO2001029049A3 Imidazole derivatives as phosphodiesterase vii inhibitors
11/01/2001US20010037030 Tricyclic amine derivatives
11/01/2001US20010036941 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolonecarboxylic acid and -naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and associated gastroduodenal disorders
10/2001
10/31/2001EP1149118A1 Method of producing derivatized polymers
10/31/2001EP0897924B1 Process for the preparation of tetrahydro-indolizines
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/30/2001US6310207 Mannich reaction
10/30/2001US6310075 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
10/25/2001WO2001079204A1 Phenyl substituted 4-hydroxy tetrahydropyridone
10/25/2001WO2001079199A1 Acetylene derivatives and herbicides containing the same
10/25/2001WO2001079188A1 Antihistaminic compounds
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001WO2001025215A3 Method for selectively dissociating cyclic carboxylic acid anhydrides
10/25/2001US20010034446 Condensed-hexacyclic compounds and a process therefor
10/25/2001US20010034444 Treating schizophrenia, depression, and Parkinson's disease; side effect reduction
10/25/2001US20010034352 Cardiovascular disorders
10/25/2001US20010034351 A quinazoline compound
10/25/2001US20010034341 Bactericides
10/25/2001DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001DE10019145A1 New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides
10/24/2001EP1147114A1 Novel aralkyl amines of spirofuropyridines useful in therapy
10/24/2001EP1147113A1 Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases
10/24/2001EP1147112A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/24/2001EP1147094A1 Non-peptide glp-1 agonists
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001EP1146790A1 Compounds and methods
10/24/2001EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001CN1318542A Synthesis of piperazine and its derivative
10/23/2001US6306889 Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
10/23/2001US6306872 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6H-pyrrolo[3′,4′:4,5]furo[3,2-b]pyrid-8(7H)-one derivatives and their use in combatting endoparasites
10/23/2001US6306869 N-oxides
10/23/2001US6306868 Methods for inhibiting the growth of tumors with 7-substituted camptothecin derivatives
10/23/2001US6306867 Treatment of respiratory system disorders, tumor necrosis factor and leukotrienes
10/23/2001CA2079189C (benzocycloalkyl) alkylamines, their preparation process and pharmaceutical compositions containing them
10/18/2001WO2001077115A1 Antitumoral ecteinascidin derivatives
10/18/2001WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
10/18/2001WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists
10/18/2001WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001US20010031880 Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
10/18/2001US20010031871 Method for producing pyridine derivatives
10/18/2001US20010031857 Memno peptides, process for their preparation and use thereof
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 298